P
186.23
-0.91 (-0.49%)
| Previous Close | 187.14 |
| Open | 186.03 |
| Volume | 189,844 |
| Avg. Volume (3M) | 260,664 |
| Market Cap | 19,460,847,616 |
| Price / Earnings (TTM) | 238.76 |
| Price / Earnings (Forward) | 238.10 |
| Price / Sales | 167.10 |
| Price / Book | 143.36 |
| 52 Weeks Range | |
| Earnings Date | 14 Aug 2024 |
| TTM Dividend Yield | 0.16% |
| Profit Margin | 51.27% |
| Operating Margin (TTM) | 73.07% |
| Diluted EPS (TTM) | 0.800 |
| Quarterly Revenue Growth (YOY) | 28.50% |
| Quarterly Earnings Growth (YOY) | 39.10% |
| Total Debt/Equity (MRQ) | 1.10% |
| Current Ratio (MRQ) | 5.98 |
| Operating Cash Flow (TTM) | 81.98 M |
| Levered Free Cash Flow (TTM) | 69.20 M |
| Return on Assets (TTM) | 30.68% |
| Return on Equity (TTM) | 50.71% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (AU) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | PROMEDICUS FPO [PME] | - | - |
AIStockmoo Score
0.0
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 0.5 |
| Average | 0.00 |
|
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Large Growth |
| % Held by Insiders | 49.29% |
| % Held by Institutions | 14.48% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |